Several studies have highlighted mechanisms which cause PD‐L1 overexpression in tumor cells of DLBCL including genetic abnormality (gains, amplifications, or translocations) of the PD‐L1 and PD‐L2. The gene discussed is PDCD1LG2; the disease is diffuse large B-cell lymphoma.